Xxxxxxxx xx 31.3.2006 xx 22.9.2007 (do xxxxxx x. 230/2007 Xx.)
Xxxxxxx x. 6 x vyhlášce x. 26/2001 Xx.
Xxxx 1
Seznam xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxxx, xxxxxxxx přípustné koncentrace, xxxxxxxxx xx čistotu xxxxxxxxx xxxxxxxxxxxxx přísad x xxxxxxxx xxxxxxx
Xx xxxxxxxxxxx xxxxxxx se xxxxxxxx x soli xxxxx, uvedených x xxxxxxx x. 6. x xx soli xxxxxxxx, xxxxx, xxxxxxxx, xxxxxxxxx, amonné, xxxxxxxxxxxxxx x xxxx chloridy, xxxxxxx, sírany, xxxxxx x xxxxxx-, ethyl-, xxxxxx, isopropyl-, xxxxx-, xxxxxxxx- x xxxxxxxxxxx.
Xxxxx xxxxxxxx xxxxxxxx (+) xxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxxxx xxxxxx x koncentraci xxxx, xxx xx x xxxxxxx x. 6 xxxxxxx, xxx jen xxx specifické xxxxx, xxxxx xxxx xxxxxx x xxxxxxxxxxx xxxxxx, xxxxxxxx xxxxx použití xxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxx xxxx dezodoranty do xxxxx xxxx xxxxxxx xxxxx lupům xx xxxxxxx.
Xxxxxxx xxxxx používané xx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx xxx xxxxxx antimikrobiální vlastnosti x mohou tak xxxxxxxxx xxxxxxxxxx xxxxxxx. Xxx xxxxxxxxx x xxxx éterických xxxxx x xxxxxxx xxxxxxxx. Xxxx xxxxx xxxxxx xxxxxxxx do přílohy x. 6.
Xxxxxxx finální xxxxxxxxxx xxxxxxxxxx, které xxxxxxxx xxxxxxxxxxx nebo xxxxx xxxxxxxxxxx uvolňující, xxxx být xx xxxxx xxxxxxxx xxxxxxxxx "xxxxxxxx xxxxxxxxxxx", xxxxx xxxxxxxxxxx formaldehydu xx xxxxxxxx xxxxxxx překročí 0,05 procent.
___________________________________________________________________________________________
Ref. Látka Maximální Omezení a xxxxxxxxx Xxxxxxxx xxxxxxx
xxxxx xxxxxxxx xxxxxxxxxxx x xxxxxxxx, která musí
být xxxxxxxxx na xxxxx
___________________________________________________________________________________________
x x x x x
___________________________________________________________________________________________
1 Xxxxxxxx benzoová•; 0,5 % v xxxxxxxx xx xxxxxxxx
/Xxxxxxx xxxx/°, xxxx xxxx
x xxxxxx (+)
___________________________________________________________________________________________
2 Xxxxxxxx xxxxxxxxxx•; 2 % v xxxxxxxx xx xxxxxxxx
/Xxxxxxxxx xxxx/°x xxxx xxxx
___________________________________________________________________________________________
3 Kyselina xxxxxxxxxx•; 0,5 % x xxxxxxxx na xxxxxxxx Xxxxx xxx xxxxxxx xx xxxxxxx pro Nepoužívat xxx xxxx
/Xxxxxxxxx xxxx /°a xxxx děti xx 3 let x xxxxxxxx xxxxxxx. xx 3 xxx (1).
xxxx (+)
___________________________________________________________________________________________
4 Xxxxxxxx xxxxxxx (hexa- 0,6 % x xxxxxxxx xx xxxxxxxx
-2,4-xxxxxxx xxxxxxxx)•;
/Xxxxxx xxxx (xxxx-2,4-
-xxxxxxx xxxx)/°x xxxx
xxxx (+)
___________________________________________________________________________________________
5 Xxxxxxxxxxx•; 0,2 % (xxxx xxxxxxxxxx xxx Xxxxxxxx x xxxxxxxxxxxxxx
/Xxxxxxxxxxxx/°x xxxxxxx xxx) xxxxxxxx (xxxxxxxx).
xxxxxxxxxxxxxxx• ; 0,1 % (xxxxxxxxxx pro hygienu
/Paraformaldehyde/°(+) úst) x xxxxxxxx xx xxxxx
xxxxxxxxxxx
___________________________________________________________________________________________
6 xxxxxxx xxxxxxxxxx
___________________________________________________________________________________________
7 Bifenyl.-2-ol(o-fenyl- 0,2 % x xxxxxxxx xx xxxxx
xxxxx)•; /Biphenyl-2-
-ol(o-phenylphenol/°)
a xxxx xxxx (+)
___________________________________________________________________________________________
8 Xxxxxxxxx xxxxxxxxx• 0,5 % Xxxxxxx xxx xxx xxxxxxxxxx,
/Xxxxxxxxxx xxxx/* (+) xxxxx se xxxxxxxxx. Xxxxxxx
x prostředcích xxxxx xxxxxxx.
___________________________________________________________________________________________
9 Xxxxxxxxxxx xxxxxxxxxx 0,2 % x xxxxxxxx xx xxxxx XX2
x xxxxxxxxxxxxxxxxxx
/Xxxxxxxxx sulphites xxx
xxxxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
10 Xxxxxxxx xxxxx 0,1 % Xxx pro xxxxxxxxxx, xxxxx
/Xxxxxx xxxxxx/° xx xxxxxxxxx.
___________________________________________________________________________________________
11 Chlorbutanol• 0,5 % Zakázáno v xxxxxxxxxxxxxx Xxxxxxxx
/Xxxxxxxxxxxx/* xxxxxxxx (sprejích). chlorbutanol.
___________________________________________________________________________________________
12 Xxxxxxxx 4- 0,4 % xxxx xxxxxxxx xxx xxxxx
-xxxxxxxxxxxxxxx•; xxxxx
/4-Xxxxxxxxxxxxxx 0,8 % xxxx xxxxxxxx xxx směs
acid/°a xxxx xxxx x xxxxxx
xxxxxx (+)
___________________________________________________________________________________________
13 3-Xxxxxx-6-xxxxxx-2,3- 0,6 % x xxxxxxxx xx xxxxxxxx Xxxxxxxx x xxxxxxxxxxxxxx
-xxxxxxx-4X-xxxxx-2,4- xxxxxxxx (xxxxxxxx).
-xxxx•; /Acetyl-6-methyl-
-pyran-2,4(3H)-dione
(Dehydroacetic xxxx)/°
x xxxx xxxx
___________________________________________________________________________________________
14 Kyselina xxxxxxxx•; 0,5 x xxxxxxxx na xxxxxxxx
/Xxxxxx xxxx/°x xxxx
xxxxx sůl/ (+)
___________________________________________________________________________________________
15 3,3´-Xxxxxx-4,4´- 0,1%
(xxxxx-1,6-xxxxxxxxx)
xxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxxx);
/3,3´-Xxxxxxx-4,4´-
-xxxxxxxxxxxxxxxxxx-
xxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxx/°
x xxxx xxxx xxxxxx
xxxxxxxxxxx•
/xxxxxxxxxxx/°(2-xxxxx-
xxxxxxx-1-xxxxxxxxx)•
___________________________________________________________________________________________
16 Xxxxxxxxxx• /Thiomersal/* 0,007 % (xxxx Xx) xx xxxxx s Pouze xxx prostředky x xxxxxx Xxxxxxxx xxxxxxxxxx.
xxxxxxxxx sloučeninami xxxxx x odličování xxx.
xxxxxxxxxx xxxxx xxxxxxxxx
xxxxxxx xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % Hg
___________________________________________________________________________________________
17 Xxxxxxxxxxxxx soli• 0,007 % (jako Xx) xx xxxxx x Xxxxx xxx xxxxxxxxxx x líčení Obsahuje
(včetně xxxxxx) xxxxxxxxx xxxxxxxxxxxx xxxxx x xxxxxxxxxx okolí xxx. xxxxxxxxxxxxx
/Xxxxxxxxxxxxxx xxxxx xxxxxxxxxx touto xxxxxxxxx xxxxxxxxxx.
(xxxxxxxxx xxxxxx)/° xxxxxxx xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % x Xx
___________________________________________________________________________________________
18 Xxxxxxxx xxxx-10-xxxxx•; 0,2 % v xxxxxxxx xx xxxxxxxx
/Xxxxx-10-xxxxx xxxx/°
x xxxx xxxx(+)
___________________________________________________________________________________________
19 Xxxxxxxxx 0,1 %
/Xxxxxxxxxx/* (+)
___________________________________________________________________________________________
20 5-xxxx-5-xxxxx-1,3-xxxxxx 0,1 % Xxx xx xxxxxxxxxx, xxxxx xx
(Xxxxxxxx)• /5-Bromo-5- oplachují.
-nitro-1,3-dioxane/° Zamezit xxxxxx nitrosaminů.
___________________________________________________________________________________________
21 Xxxxxxxx /Xxxxxxxx/* (+) 0,1 % Xxxxxxx xxxxxx xxxxxxxxxxx.
___________________________________________________________________________________________
22 2,4-Xxxxxxx-xxxxxx- 0,15 %
xxxxxxx• /2,4-Xxxxxxxx-
xxxxxx xxxxxxx/°(+)
___________________________________________________________________________________________
23 Xxxxxxxxxxxx 0,2 % Xxxxxxxx xxxxxxx: 3,3´,4,4´-
/Xxxxxxxxxxxx/* (+) xxxxxxxxxxxxxxxxxxx méně xxx 1
xxx 3,3´,4,4´-tetrachlorazoxy-
benzen xxxx xxx 1 xxx
___________________________________________________________________________________________
24 4-Xxxxx-x-xxxxxx• 0,2% Zakázán v xxxxxxxxxxxx
/4-Xxxxxx-x-xxxxxx/°(+) xxxxxxxxxxxxxx do xxxxxxxx
xx xxxxxxxx.
___________________________________________________________________________________________
25. Xxxxxxxxx /Xxxxxxxxx/* (+) 0,3 %
___________________________________________________________________________________________
26 4-Xxxxx-3,5-xxxxxxx(4- 0,5 %
-xxxxx-3,5-xxxxxxxxxxxxx)•
/4-Xxxxxx-3,5-xxxxxxx/°(+)
___________________________________________________________________________________________
27 3,3´-Bis[1-(hydroxy- 0,6 %
xxxxxx)-2,5-xxxxxxxxxx-
xxxxxxx-4-xx]-1,1´-
xxxxxxxxxxxxxxxxxx
(xxxxxxxxxxxxxxxxxxxxxx)•
/3,3´--Xxx(1-xxxxxxx-
xxxxxx-2,5-xxxxxxxxxx-
xxxxxxx-4-xx)-1,1´-xxxxxx-
xxx-xxxxx ("Xxxxxxxxxxxxxx
xxxx") /°(+)
___________________________________________________________________________________________
28 Xxxx-1-xxxxxxxxxxxx 0,3 %
biguanid-hydrochlorid•
/Poly-(1-hexamethyl-
enbiguanide xxxxx-
xxxxxxxx/°(+)
___________________________________________________________________________________________
29 2-Xxxxxxxxxxx-1-xx• 1 %
/2-Xxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
30 Hexamethylentetramin 0,15 %
(methenamin, xxxxxxxxx)•
/Xxxxxxxxxxxxxxxxxxxxx
(xxxxxxxxxxx*)/°(+)
___________________________________________________________________________________________
31 Xxxxxxxxxx-3-xxxxxx- 0,2 %
-xxxxxxxxxxxx•
/Xxxxxxxxxxx-3-xxxxxx-
xxxxxxxxxxxxx/°(XXXX)
___________________________________________________________________________________________
32 1-(4-Xxxxxxxxxxx)-1- 0,5 %
(xxxxxxxx-1-xx)-3,3´-
xxxxxxxxxxxxx-2-xx•
/1-(4-Xxxxxxxxxxxxx)-
-1-(xxxxxxxx-1-xx)3,3-
-xxxxxxxxxxxxx-2xxx/°
(+)
___________________________________________________________________________________________
33 1,3-Xxx(xxxxxxxxxxxxx)- 0,6 %
-5,5-xxxxxxxxxxxxxxxxxxxx-
2,4-xxxx• /1,3-Xxx
(xxxxxxx-xxxxxx)-5,5-
-xxxxxxxx-xxxxxxxxxxxxx-
-2,4-xxxxx/°(+)
___________________________________________________________________________________________
34 Xxxxxxxxxxxxx• 1 %
/Xxxxxx xxxxxxx/°
___________________________________________________________________________________________
35 1-Xxxxxxx-4-xxxxxx-6- 1 % Xxx xxxxxxxxxx, které se xxxxxxxxx.
(2,4,4-xxxxxxxxxxxxxxx)
xxxxxxx-2(1X)-xx•;
/1-Xxxxxxx-4-xxxxxx-6 0,5 % Xxx ostatní xxxxxxxxxx.
(2,4,4-xxxxxxxxx-xxxxxx)
2-xxxxxxx/°x xxxx
xxxxxxx x xxxxxxxxxx-
xxxxxxx• (xxxxxxxxx) (+)
___________________________________________________________________________________________
36 1,2-Xxxxxx-2,4- 0,1 % Xxxxx xxx prostředky, xxxxx
xxxxxxxxxxx• xx oplachují.
/1,2-Dibromo-2,4-
-dicyanobutane°
METHYLDIBROMO
GLUTARONITRILE•
___________________________________________________________________________________________
37 6,6´-Xxxxxx-4,4-´xxxxxxx- 0,1 %
-2,2-´xxxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxx)
/6,6-Xxxxxxx-4,4-xxxxxxxx-
2,2-´xxxxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxx)/°(+)
___________________________________________________________________________________________
38 4-Xxxxxxxxx-x-xxxxxx 0,1 %
(4-isopropyl-3-methylfenol)•
/4-Isopropyl-m-cresol/°
___________________________________________________________________________________________
39 Xxxx 5-chlor-2-methyl- 0,0015 % (Xxxx x xxxxxx 3 :1
-isothiazol-3(2H)-onu• 5-xxxxx-2-xxxxxx-xxxxxxxxxx-3(2X)-
/5-xxxxxx-2-xxxxxxx- -xx a 2-methylisothiazol-3(2H)-on
sothiazol-3(2H)-one/°a
2-methylisothiazol-3(2H)-
-onu• /2-xxxxxxxxxxxxxxxx-
3(2X)-xxx/°x chloridem
hořečnatým /magnesium
chloride/°a xxxxxxxxxx
xxxxxxxxxx /xxxxxxxxx
xxxxxxx/°
___________________________________________________________________________________________
40 2-Xxxxxx-4-xxxxxxxxxx• 0,2 %
(Xxxxxxxxx) /2-Xxxxxx-4-
-xxxxxxxxxxx
(Xxxxxxxxxxx)/°
___________________________________________________________________________________________
41 Xxxxxxxxxxxxx• 0,3 % Xxxxxxxx
/2-Xxxxxxxxxxxxxx/° xxxxxxxxxxxxx.
___________________________________________________________________________________________
42 Xxxxxxxxxxxx• 0,3 % x xxxxxxxx xx chlorhexidin
/Chlorhexidine/* x xxxx
xxxxxxxxxx, /digluconate/°,
diacetát /xxxxxxxxx/ a
dihydrochlorid
/dihydrochloride/°(+)
___________________________________________________________________________________________
43 1-Xxxxxxxxxxxx-2-xx• 1,0 % Xxx pro xxxxxxxxxx, xxxxx xx
/1-Xxxxxxxxxxxxx-2-xx/° xxxxxxxxx.
___________________________________________________________________________________________
44 Xxxxx (X12 - C22) 0,1 %
xxxxxxxxxxxxxxxxxxxxxx
x -chlorid•
/Alkyl (X12 - X22) trimethyl
ammonium-bromide
a xxxxxxxx/°(+)
___________________________________________________________________________________________
45 4,4-Xxxxxxxx-1,3- 0,1 % pH xxxxxxxxx xxxxxxxx xxxxx
-xxxxxxxxxx• /4,4-Xx- xxx xxxxx xxx 6.
xxxxxx-1,3-xxxxxxxxxxx/
___________________________________________________________________________________________
46 1-[1,3-Xxx(xxxxxxx- 0,5 %
-xxxxxx)-2,5-xxxxx-
xxxxxxxxxxxx-4-xx]-1,3-
-xxx(xxxxxxxxxxxxx)
xxxxxxxx•
/X-(Xxxxxxxxxxxxx)-X-
-(xxxxxxxxxxxxxxx-1,3-
-xxxxx-2,5-xxxxxxxxxxx-
xxx-4)X´-(xxxxxxx-
xxxxxx)xxxx/
___________________________________________________________________________________________
47 4,4-´(Hexan-1,6-diyldi- 0,1 %
xxx)xxxxxxxxxxxxxx•
/1,6-Xx(4-xxxxxxxxxxxx-
xx)-x-xxxxxx(Xxxxxxxx-
xx)/°x xxxx xxxx xxxxxx
xxxxxxxxxxx (2-xxxxxxx-
-xxxxx-1-xxxxxxxxx)•
/xxxxxxxxxxx/°x 4-xxxxx-
xxxxxxxxxx• /x-xxxxx-
xxxxxxxxxx/°(+)
___________________________________________________________________________________________
48 Xxxxxxxxxxxxxx 0,1 % Xxxxxxxx x xxxxxxxxxxxxxx Xxxxxxxx
(xxxxxxxxxx)• aerosolů (xxxxxxxx). xxxxxxxxxxxxx.
/Xxxxxxxxxxxxx (xxx xxxxxx
(Xxxxxxx-1,5-xxxx)/° glutaraldehydu x
xxxxxxxx produktu
vyšším xxx 0,05 %)
___________________________________________________________________________________________
49 5-Ethyl-3,7-dioxa-1- 0,3 % Zakázán x prostředcích ústní
-azabicyklo[3.3.0]oktan• xxxxxxx x x xxxxxxxxxxxx
/5-Xxxxx-3,7-xxxxx-1- xxxxxxxxxxxxxx do xxxxxxxx
-xxxxxxxxxx[3.3.0] xx sliznicí.
octane/°
___________________________________________________________________________________________
50 3-(4-Xxxxxxxxxxx)-xxxxxx- 0,3 %
-1,2diol• (Xxxxxxxxxxxx)
/3-(x-Xxxxxxxxxxxx)-
-xxxxxxx-1,2-xxxx
(Xxxxxxxxxxxxx)/°
___________________________________________________________________________________________
51 [(Xxxxxxxxxxxxx)xxxxx] 0,5 %
xxxxxx sodný, X-(xxxxxxx-
xxxxxx)-xxxxxxxx xxxxx,•
/Xxxxxx hydroxymethyla-
minoacetate, (Xxxxxx
xxxxxxxxxxxxxxxxxxxxxx)/°
___________________________________________________________________________________________
52 Xxxxxxx xxxxxxxx xxxxx- 0,004 % v xxxxxxxx xx XxXx 20 % (xxxxx.)XxXx na XxX2
xxxx na xxxxx xxxxxxxxxxx Zakázán v xxxxxxxxxxxx xxx xxxx xx
/Xxxxxx chloride xxxxxxxxx 3 let, x xxxxxxxxxxxx ústní hygieny
on Xxxxxxxx xxxxxxx/° x x xxxxxxxxxxxx xxxxxxxxxxxx do
okolí xxx a xx xxx.
___________________________________________________________________________________________
53 Xxxxxx{2-[2-(xxxxxxxxxxxx- 0,1 % x) xxxxxxxxxx, které xx oplachují;
noxy)ethoxy]ethyl}di- b) prostřeky, xxxxx xxxxxxxxx xx xxxx, vyjma xxxxxxxxxx
xxxxxxxxxxxxx-xxxxxxx xxx péči o xxxxxx xxxxx
Xxxxxxxxxxxx-xxxxxxx•
XXXXXXXXXXXX CHLORIDE°
___________________________________________________________________________________________
54 Alkyl(C8 - X18) (xxxxxx) 0,1 % x xxxxxxxx xx Xxxxxxx xxxxx x xxxxx.
xxxxxxxxxxxxxxx-xxxxxxx, xxxxxxxxxxxx-xxxxxxx
-xxxxxx a xxx s xxxxxxxx
xxxxxxxxx (xxxxxxxxxxxx
-xxxxxxx, -xxxxxx x xxx s
cukernou kyselinou)•
/Benzalkonium xxxxxxxx,
xxxxxxx xxx
xxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
55 Benzylhemiformal 0,15 % Xxx xxx xxxxxxx, xxxxx se
(benzyloxymethanol)• xxxxxxxxxx xxxxxxxxxxxx.
/Xxxxxxxxxxxxxxxx/°
___________________________________________________________________________________________
56 3-Xxxxxxx-2-xx-1-xx-X- 0,05 % 1. Nesmí xx používat x Xxxxxxxx xxx.
-xxxxxxxxxxxxx• xxxxxxxxxxxx xxxxx xxxxxxx x v
/3-Iodo-2-propynyl-butyl- prostředcích x xxxx x xxx.
xxxxxxxxx/° 2. Xxxxx xxxxxxxxxxx x
xxxxxxxxxxxx, xxxxx xxxx určeny
k xxxx, xxx xxxxxxxxx xx
xxxxxxx, xxxxxxxx 0,02 %,
xxxxxxxx xxxx: Xxxxxxxx xxx.
___________________________________________________________________________________________
57 2-xxxxxxxxxxxxxxxx- 0,01 %
-3(2X)-xx•
XXXXXXXXXXXXXXX-
XXXXXX°
___________________________________________________________________________________________
(1) Xxxxx xxxxx xxx xxxxxxx, které xx mohly xxx xxxxxxx pro děti xx 3 xxx x xxxxx xxxxxxxxx x prodlouženém xxxxxxxx x xxxx.
(*) X xxxx xxxxxxx xx xxxxx xxxxxxxx označen xxxxx publikovaný x xxxxxxx xxxxxxxxxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxxxxxx xxxxxxx "Computer print-out 1975, International Xxx-xxxxxxxxxxx Xxxxx (XXX) xxx xxxxxxxxxxxxxx products Xxxxx 1,33 xx xxxxxxxx XXX", WHO, Xxxxxx, Xxxxxx 1975.
(•) X xxxx xxxxxxx xx xxxxx způsobem označen xxxxx xxxxxxxxx xxxxx "Xxxxxxxx xxxxxxxxxxx organických xxxxxxxxx xxxxx IUPAC (Xxxxxxxxxx 1993)", Xxxxxxxx, Xxxxx 2000.
(°) V xxxx xxxxxxx xx xxxxx xxxxxxxx xxxxxxx xxxxx v xxxxxxxxx xxxxxx, xxxxxxxx x xxxxxxxxx "Xxx Cosmetics Xxxxxxxxx 76/768/XXX", Colipa, Xxxxxxxx, Xxxxx 2000.
Xxxx 2
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxx xxxxxxxxxx v xxxxxxxxxxxx xxxxxxxxxxxx, xxxxxxxx xxxxxxxxx xxxxxxxxxxx, požadavky xx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx přísad a xxxxxxxx použití
_______________________________________________________________________________________
Ref. číslo Látka Maximální Xxxxxxx x Xxxxxxxx xxxxxxx x xxxxxxxx,
xxxxxxxx požadavky která xxxx být xxxxxxxxx xx
xxxxxxxxxxx xxxxx
_______________________________________________________________________________________
x x c x x
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Xxxxxxxx: X xxxxxxxx xxxx tato xxxxxxx neobsahuje xxxxxx xxxxx.